Ulrich‐Peter Rohr
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
Papers in
- Oncology 10
- Lung Cancer Research Studies 3
- Cancer Treatment and Pharmacology 2
-
- RNA Interference and Gene Delivery 4
- Co-authors
- Ralf Kronenwett (16 shared papers)Rainer Haas (16 shared papers)Roland Fenk (14 shared papers)James T. Cassidy (2 shared papers)Herbert I. Hurwitz (2 shared papers)Leonard B. Saltz (2 shared papers)Ulrich Steidl (9 shared papers)Peter G. Compton (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Blood (4 papers)Clinical Cancer Research (3 papers)Cancer Gene Therapy (2 papers)Neuro-Oncology (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Ulrich‐Peter Rohr
35 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 112
- Hematology 231
- Oncology 472
- Internal Medicine 52
- Genetics 133
- Pulmonary and Respiratory Medicine 249
Countries citing papers authored by Ulrich‐Peter Rohr
This map shows the geographic impact of Ulrich‐Peter Rohr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich‐Peter Rohr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich‐Peter Rohr more than expected).
Fields of papers citing papers by Ulrich‐Peter Rohr
This network shows the impact of papers produced by Ulrich‐Peter Rohr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich‐Peter Rohr. The network helps show where Ulrich‐Peter Rohr may publish in the future.
Co-authors
The 25 scholars most cited alongside Ulrich‐Peter Rohr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 175 | |
| 2 | 2011 | 154 | |
| 3 | 2016 | 140 | |
| 4 | 2002 | 121 | |
| 5 | 2009 | 118 | |
| 6 | 2002 | 118 | |
| 7 | 2001 | 110 | |
| 8 | 2004 | 97 | |
| 9 | 2008 | 57 | |
| 10 | 2005 | 53 | |
| 11 | 2021 | 43 | |
| 12 | 2004 | 35 | |
| 13 | 2006 | 29 | |
| 14 | Levels of minimal residual disease detected by quantitative molecular monitoring herald relapse in patients with multiple myeloma. | 2004 | 28 |
| 15 | 2005 | 27 | |
| 16 | 2017 | 23 | |
| 17 | 2006 | 21 | |
| 18 | 2002 | 19 | |
| 19 | 2015 | 17 | |
| 20 | 2005 | 10 |
About Ulrich‐Peter Rohr
Ulrich‐Peter Rohr is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Hematology and Genetics, having authored 36 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (4 papers), Virus-based gene therapy research (4 papers), Lung Cancer Research Studies (3 papers), Brain Metastases and Treatment (3 papers), Multiple Myeloma Research and Treatments (3 papers), Viral Infections and Immunology Research (3 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Hematology (231 citations), Oncology (472 citations), Internal Medicine (52 citations), Genetics (133 citations) and Pulmonary and Respiratory Medicine (249 citations). Ulrich‐Peter Rohr has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Ralf Kronenwett, Rainer Haas, Roland Fenk, James T. Cassidy, Herbert I. Hurwitz, Leonard B. Saltz, Ulrich Steidl, Peter G. Compton, Benjamin Besse and Jane Huang. Their work appears in journals such as Journal of Clinical Oncology, Blood, Clinical Cancer Research, Cancer Gene Therapy and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.